Back
BioMarin Pharmaceutical Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
65
BMRN
BioMarin Pharmaceutical
Last Price:
$58.34
Seasonality Move:
-2.05%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BMRN is experiencing buying pressure, which is a positive indicator for future bullish movement.
BioMarin Pharmaceutical Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 58.15 | Buy |
| 20-day SMA: | 56.42 | Buy |
| 50-day SMA: | 57.5 | Buy |
| 200-day SMA: | 64.09 | Sell |
| 8-day EMA: | 57.78 | Buy |
| 20-day EMA: | 57.23 | Buy |
| 50-day EMA: | 58.11 | Buy |
| 200-day EMA: | 65.19 | Sell |
BioMarin Pharmaceutical Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.28 | Buy |
| Relative Strength Index (14 RSI): | 55.47 | Buy |
| Chaikin Money Flow: | 1302820 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (54.94 - 58.08) | Buy |
| Bollinger Bands (100): | (56 - 67.88) | Sell |
BioMarin Pharmaceutical Technical Analysis
| Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for BioMarin Pharmaceutical Stock
Is BioMarin Pharmaceutical Stock a Buy?
-
BioMarin Pharmaceutical share price is 58.39 while BMRN 8-day simple moving average is 58.15, which is a Buy signal.
-
The stock price of BMRN is 58.39 while BioMarin Pharmaceutical 20-day SMA is 56.42, which makes it a Buy.
-
BioMarin Pharmaceutical 50-day simple moving average is 57.50 while BMRN share price is 58.39, making it a Buy technically.
-
BMRN stock price is 58.39 and BioMarin Pharmaceutical 200-day simple moving average is 64.09, creating a Sell signal.
BMRN Technical Analysis vs Fundamental Analysis
Buy
65
BioMarin Pharmaceutical (BMRN)
is a Buy
Is BioMarin Pharmaceutical a Buy or a Sell?
-
BioMarin Pharmaceutical stock is rated a BuyThe current BioMarin Pharmaceutical [BMRN] share price is $58.39. The Score for BMRN is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
BioMarin Pharmaceutical Stock Info
Market Cap:
11.2B
Price in USD:
58.39
Share Volume:
1.7M
BioMarin Pharmaceutical 52-Week Range
52-Week High:
94.85
52-Week Low:
52.93
Buy
65
BioMarin Pharmaceutical (BMRN)
is a Buy
BioMarin Pharmaceutical Share Price Forecast
-
What is the BioMarin Pharmaceutical stock price today?The BioMarin Pharmaceutical stock price is 58.39 USD today.
-
Will BMRN stock go up or go down?BioMarin Pharmaceutical> share price is forecast to RISE/FALL based on technical indicators
-
Is BioMarin Pharmaceutical overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, BioMarin Pharmaceutical is not overvalued.
Is BioMarin Pharmaceutical Stock a Buy?
-
BioMarin Pharmaceutical share price is 58.39 while BMRN 8-day exponential moving average is 57.78, which is a Buy signal.
-
The stock price of BMRN is 58.39 while BioMarin Pharmaceutical 20-day EMA is 57.23, which makes it a Buy.
-
BioMarin Pharmaceutical 50-day exponential moving average is 58.11 while BMRN share price is 58.39, making it a Buy technically.
-
BMRN stock price is 58.39 and BioMarin Pharmaceutical 200-day simple moving average is 65.19, creating a Sell signal.
Fundamental Analysis of BioMarin Pharmaceutical
Is BioMarin Pharmaceutical a good investment?
-
Analysts estimate an earnings increase this quarter of $0.17 per share, an increase next quarter of $0.33 per share, an increase this year of $0.93 per share, and an increase next year of $1.20 per share.
Technical Analysis of BioMarin Pharmaceutical
Should I short BioMarin Pharmaceutical stock?
-
BMRN Moving Average Covergence Divergence (MACD) indicator is 0.28, suggesting BioMarin Pharmaceutical is a Buy
-
BioMarin Pharmaceutical Relative Strength Index (RSI) is 55.47, which suggest BioMarin Pharmaceutical is overbought
-
The Bollinger Bands (25) for BioMarin Pharmaceutical is (54.94 - 58.08), which suggest BioMarin Pharmaceutical is a Sell
-
The Bollinger Bands (100) for BioMarin Pharmaceutical is (56 - 67.88), which suggest BioMarin Pharmaceutical is a Sell
* BioMarin Pharmaceutical stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.